Press Resease

Precision Medicine Market By Technology (Bioinformatics, Genomic Sequencing, Drug Discovery, Companion Diagnostics, Big Data Analytics Software, and Others), By Application (Oncology, Immunology, Respiratory, CNS, and Others), and By End-User (Pharmaceutical Companies, Biotechnology Companies, Diagnostic Laboratories, Healthcare-IT/Big Data Firms, Clinical Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 21-Aug-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3876 Status : Published

Global precision medicine market anticipated to reach around USD 86.25 billion by 2025, growing at a CAGR of around 10.1% between 2019 and 2025. The increasing acceptance rate of gene therapies in developed economies with a comparatively high-revenue can enhance the precision medicine market growth in the years ahead.

Description

The report covers a forecast and an analysis of the precision medicine market on a global and regional level. The study provides historical data from 2016 to 2018The  along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the precision medicine market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the precision medicine market on a global and regional level.

In order to give the users of this report a comprehensive view of the precision medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Precision Medicine Market

The report provides company market share analysis to give a broader overview of the key players in the precision medicine market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the precision medicine market on a global and regional basis.

The study contributes a conclusive view of the precision medicine market by segmenting the market based on technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players of the precision medicine market are Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.

This report segments the global precision medicine market into:

Precision Medicine Market: By Technology

  • Bioinformatics
  • Genomic Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Big Data Analytics Software
  • Others

Precision Medicine Market: By Application

  • Oncology
  • Immunology
  • Respiratory
  • CNS
  • Others

Precision Medicine Market: By End-User

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Diagnostic Laboratories
  • Healthcare-IT/Big Data firms
  • Clinical Laboratories
  • Others

Precision Medicine Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Precision Medicine Market Revenue, 2016-2025 (USD Billion)
    • 2.2. Global Precision Medicine Market: Snapshot
  •  
  • Chapter 3. Precision Medicine Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Precision Medicine Market Drivers: Impact Analysis
      • 3.2.2. Increasing Prevalence of Cancer
      • 3.2.3. Increasing adoption of targeted therapy
    • 3.3. Market restraints
      • 3.3.1. High capital investments
    • 3.4. Opportunities
      • 3.4.1. Emerging markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Technology
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Precision Medicine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Precision Medicine Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Precision Medicine Market - Technology Analysis
    • 5.1. Global Precision Medicine Market: Technology overview
      • 5.1.1. Global Precision Medicine Market share, by Technology, 2018 and 2025
    • 5.2. Bioinformatics
      • 5.2.1. Global Precision Medicine Market for Bioinformatics, 2016-2025 (USD Billion)
    • 5.3. Genomic Sequencing
      • 5.3.1. Global Precision Medicine Market for Genomic Sequencing, 2016-2025 (USD Billion)
    • 5.4. Drug Discovery
      • 5.4.1. Global Precision Medicine Market for Drug Discovery, 2016-2025 (USD Billion)
    • 5.5. Companion diagnostics
      • 5.5.1. Global Precision Medicine Market for Companion diagnostics, 2016-2025 (USD Billion)
    • 5.6. Big data Analytics Software
      • 5.6.1. Global Precision Medicine Market for Big data Analytics Software, 2016-2025 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global Precision Medicine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Precision Medicine Market - Application Analysis
    • 6.1. Global Precision Medicine Market: Application overview
      • 6.1.1. Global Precision Medicine Market share, by Application, 2018 and 2025
    • 6.2. Oncology
      • 6.2.1. Global Precision Medicine Market for Oncology, 2016-2025 (USD Billion)
    • 6.3. Immunology
      • 6.3.1. Global Precision Medicine Market for Immunology, 2016-2025 (USD Billion)
    • 6.4. Respiratory
      • 6.4.1. Global Precision Medicine Market for Respiratory, 2016-2025 (USD Billion)
    • 6.5. CNS
      • 6.5.1. Global Precision Medicine Market for CNS, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global Precision Medicine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Precision Medicine Market - End-User Analysis
    • 7.1. Global Precision Medicine Market: End-User overview
      • 7.1.1. Global Precision Medicine Market share, by End-User, 2018 and 2025
    • 7.2. Pharmaceuticals Companies
      • 7.2.1. Global Precision Medicine Market for Pharmaceuticals Companies, 2016-2025 (USD Billion)
    • 7.3. Biotechnology Companies
      • 7.3.1. Global Precision Medicine Market for Biotechnology Companies, 2016-2025 (USD Billion)
    • 7.4. Diagnostic Laboratories
      • 7.4.1. Global Precision Medicine Market for Diagnostic Laboratories, 2016-2025 (USD Billion)
    • 7.5. Healthcare-IT/Big Data Firms
      • 7.5.1. Global Precision Medicine Market for Healthcare-IT/Big Data Firms, 2016-2025 (USD Billion)
    • 7.6. Clinical laboratories
      • 7.6.1. Global Precision Medicine Market for Clinical laboratories, 2016-2025 (USD Billion)
    • 7.7. Others
      • 7.7.1. Global Precision Medicine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Precision Medicine Market - Regional Segment Analysis
    • 8.1. Global Precision Medicine Market: Regional overview
      • 8.1.1. Global Precision Medicine Market revenue share, by Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 8.2.2. North America Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.2.3. North America Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.2.4.2. The U.S. Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.4.3. The U.S. Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.2.5.2. Rest of North America Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.5.3. Rest of North America Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 8.3.2. Europe Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.3. Europe Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.3.4.2. Germany Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.4.3. Germany Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.5. The U.K.
        • 8.3.5.1. U.K. Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.3.5.2. U.K. Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.5.3. U.K. Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.3.6.2. France Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.6.3. France Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.4.4.2. China Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.4.3. China Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.4.5.2. Japan Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.5.3. Japan Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.4.6.2. India Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.6.3. India Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 8.5.2. Latin America Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.5.3. Latin America Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.5.4.2. Brazil Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.4.3. Brazil Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Precision Medicine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Precision Medicine Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Precision Medicine Market Revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Eagle Genomics
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Biocrates Life Sciences
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Teva Pharmaceuticals
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Quest Diagnostics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Qiagen
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Silicon Biosystems
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Nanostring Technologies
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Ferrer inCode Overview
      • 9.8.1. Financials
      • 9.8.2. Product Portfolio
      • 9.8.3. Business strategy
      • 9.8.4. Recent developments
    • 9.9. Laboratory Corporation of America Holdings
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Pfizer
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Hoffmann-La Roche
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product Portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Tepnel Pharma Services
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product Portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments

Methodology

Free Analysis

Precision medication (PM) is a form of medication that uses data about a person’s genes, proteins, lifestyle, and environment to forestall, diagnose, and treat diseases. It is an emerging approach that proposes the customization of aid with medical alternatives, treatments, practices, or merchandise that are being tailored for an individual patient.

Modern developments in applications of big data technologies for the correct detection of diseases are driving the precision drugs market. In addition, important company players are concentrating their efforts on improving software systems that support drug discovery procedures, which, in turn, helps in storing huge amounts of genetic information, thereby supporting the medicine precision market. However, deviation from treatment-based to preventive healthcare, abstaining trends in food and drug administration pharmacotherapy approval rate, the encroachment of privacy rules, and misconception of genetic and health data may limit the precision medicine market growth.

Global Precision Medicine Market

The global precision medicine market is classified based on technology, application, and end-user. By technology, the market is divided into drug discovery, big data analytics, bioinformatics, companion diagnostics, genomic sequencing, and others. The drug discovery segment holds the largest market share, of about 25%, which is closely followed by companion diagnostics and genomic sequencing. Based on application, the market includes respiratory, oncology, CNS, immunology, and others. Oncology is likely to witness the highest CAGR in the market over the forecast timeframe. Immunology accounted for the second-largest market share in 2018 and is anticipated to indicate similar growth trends over the forthcoming years. By end-user, the market includes pharmacy and biotechnology firms, diagnostic companies, healthcare-IT/big data firms, clinical laboratories, and others. Healthcare-IT/big data firms are predicted to hold a substantial share in the precision medicine market over the estimated timeframe.

North America is likely to account for the most important share of the precision medicine market over the forecast timeframe, owing to the increasing geriatric population suffering from chronic diseases like cancer, cardiovascular diseases, diabetes, etc. The Asia Pacific precision medicine market is projected to grow notably in the future, owing to the rising burden of genetic diseases in China that will drive the demand for gene therapies. Government of China has taken initiatives to fund the Chinese precision medicine market growth, which will advance the Asia Pacific precision medicine market growth in the future.

Some major players of the precision medicine market are Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social